FIDIA IN
JOINT CARE
At Fidia Farmaceutici, we are dedicated to improving the lives of individuals suffering from musculoskeletal conditions. With over 30 years of experience in joint care, our focus is on developing innovative treatments that address the root causes of joint pain and dysfunction.
WE ARE FIDIA
We are an Italian multinational, established in 1946, with a vocation to create solutions to meet new challenges in health and improve people’s true quality of life
We have understood the regenerating potential of hyaluronic acid since the 1950s and today we are one of the leading global players in the manufacture of hyaluronic acid-based products. Full control of the supply chain, from research to marketing, sets us apart and for this reason we define ourselves as a fully integrated company.
OUR SOLUTIONS
CHONDROPROTECTION
Our food supplements line offers the necessary contribution for a correct metabolism of the joints, to contribute every day to prevent and slow down the physiological progression of joint damage.
VISCOSUPPLEMENTATION
Our hyaluronic acid portfolio is very complete, because it includes the treatment for osteoarthritis and for tendinopathy.
For the treatment of osteoarthritis we have different solutions for every doctor’s and patient’s need.
REGENERATIVE CARE
A comprehensive portfolio for obtaining high-quality autologous biological products at the point-of-care. This science-based approach enables physicians to customize regenerative therapies with a high safety and efficacy profile, tailored to the unique needs of every patient.
OUR INNOVATION
Hyaluronic acid plays a crucial role in maintaining lubrication and cushioning within the joints, helping them move smoothly and reducing pain and stiffness.
HYADD®4 is an innovative hyaluronic acid hydrogel developed by Fidia Farmaceutici. This advanced formulation features a unique hexadecylamide derivative of hyaluronic acid, enhancing its viscoelastic properties and prolonging its residence time in the joint.
